The disclosure provides methods and compositions for the treatment of vascular, autoimmune and inflammatory diseases using a combination of an inosine monophosphate dehydrogenase (IMPDH) inhibitor and a HMG CoA reductase inhibitor.
Web www.patentalert.com
< 70 human secreted proteins
< Benzamide modulators of metabotropic glutamate receptors
> Insulin secretion potentiator
> Indole-derivative modulators of steroid hormone nuclear receptors
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT